ORAL DRUG DELIVERY ARTICLES
The EU’s Ban On TiO2 In Food May Impact Pharma. Here’s What You Should Know.
Titanium dioxide (TiO2) is used as a food additive and OSD pharmaceutical excipient. In 2020, the European Food Safety Authority noted data gaps regarding particle size, which can affect its toxicological properties, so the European Commission banned it as a food additive. Here's how this could impact pharma.
ORAL DRUG DELIVERY VIDEOS
Review co-amorphous research and recent findings, particularly the impact of low molecular weight excipient on developability, stability, and solubility.
Learn how to avoid common pitfalls in the transfer and scale-up process using an integrated approach, with industry experts sharing key considerations when planning for scale-up of a development program.
Learn more about defining the spray drying process with an emphasis on specific enhancements to accommodate scale-up to commercial scale equipment of challenging applications or molecules.
Experts share principles, advantages and disadvantages of different dose forms, and considerations for selecting a suitable dosage form for early phase development programs to commercialization.
ORAL DRUG DELIVERY RESOURCES
-
![GettyImages-1346739457-environmental-sustainability-pill-tablet-capsule-OSD-green]( "Reducing Environmental Impact At All Stages Of The Medicine Journey")
Explore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product to patients with greener logistics.
-
![GettyImages-1465073112-tablet-pill-OSD]( "Patient-Centric Solutions To Optimize Medication Adherence")
Explore how orally disintegrating tablets act as a patient-centric solution to various factors that impact treatment adherence rates across various diseases.
-
![Pharm Manufacturing Facility GettyImages-1087218874]( "Accelerate Development Of Enabled Formulations For Poorly Soluble Drugs")
Explore how a platform which integrates drug substance, drug product, and clinical testing within a single organization accelerates development and reduces project costs, helping deliver positive outcomes earlier.
-
![Lonza 1]( "Engineering Approaches To Respiratory Drug Delivery")
Explore the material and performance properties of spray-dried and jet-milled mannitol for respiratory delivery of crystalline mannitol.
-
![GettyImages-1300035668-nanoparticle-particle]( "Exploring Lipid Nanoparticles For Drug Delivery")
Using lipid nanoparticles (LNP) for drug delivery is a promising area of research. Discover the benefits of LNP delivery, the different types of lipid nanoparticles, their safety for drug delivery, and more.
-
![GettyImages-1327620750-lab-research]( "The Role Of Micronization In The Journey To Drug Product Development")
Micronization is an incredibly important step of the process of transitioning a compound from initial discovery into the clinic. Learn more about the key benefits of micronization.
-
![GettyImages-638678086-analytics_screen_medical_innovation]( "From Nanoformed Powder To 3D Printable Ink")
3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Explore the possibilities of forming stable suspension in printing ink from nanoformed materials.
ORAL DRUG DELIVERY SOLUTIONS
-
![ulab thumb]( "Battelle uLAB")
This comprehensive suite of services encompasses the entire spectrum of user research, starting from the conceptualization of study designs to meticulous data analysis and comprehensive reporting.
-
![GettyImages-884796056-solubility-test-pill]( "Pharmaceutical Development")
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.
-
![Nanoform]( "Controlled Expansion Of Supercritical Solutions (CESS®) Technology")
Nanoform’s award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology is a bottom-up nanoparticle engineering approach that enables the creation of API nanoparticles and can unlock the full therapeutic potential of small molecule drugs.
-
![iStock-823447656-vector-viral-lab-AAV-cell-development]( "Global Experts In Nanotechnology And Drug Particle Engineering")
Discover the nanoparticle engineering, formulation and GMP manufacturing services that can drive forward your market success and unlock the power of “small."
-
![GettyImages-1354171846-lab-research-development]( "End-To-End Drug Development, Analytical Testing, & Fill/Finish")
August Bioservices is a US-based, quality-driven CDMO that offers end-to-end drug development, analytical testing, and fill/finish manufacturing services to clients of all sizes and stages, from pre-clinical to commercial.
-
![Pills tablets capsules]( "Modified-Release Formulation Strategies")
Learn what oral modified-release (MR) dosage forms can offer and why they continue to rise in popularity.
-
![iStock-1219894397-lab-cleanroom-computer-team]( "Sterile Formulation Development")
With over 20 years of experience, PCI’s strength lies in our ability to manage products with unique challenges ranging from small molecules presenting with solubility issues or a labile molecule that is only stable as a liquid presentation for a short time.
-
![iStock-823447656-vector-viral-lab-AAV-cell-development]( "Formulation Strategies For Poorly Soluble Molecules")
As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.
-
![iStock-493302504-scientist-lab-development]( "Pre-Formulation And Material Sciences")
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
![iStock-640282108-fill-equipment-finish]( "cGMP Aseptic Manufacturing And Sterile Fill-Finish")
Experienced CDMOs will implement a cGMP aseptic manufacturing and sterile fill-finish policy to improve drug bioavailability. Aseptic fill-finish is a process in which the drug product, container, and container closure are sterilized separately and then integrated. Combining the drug, container, and closure in a clean room using special equipment that is self-contained in a sterile environment meets FDA guidelines related to cGMP.
